Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on September 5, 2006
Molecular Human Reproduction 2006 12(11):661-669; doi:10.1093/molehr/gal075
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/11/661    most recent
gal075v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ponnampalam, A.P.
Right arrow Articles by Rogers, P.A.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponnampalam, A.P.
Right arrow Articles by Rogers, P.A.W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Cyclic changes and hormonal regulation of annexin IV mRNA and protein in human endometrium

A.P. Ponnampalam and P.A.W. Rogers1

Centre for Women’s Health Research, Monash Institute of Medical Research, Monash University Department of Obstetrics and Gynaecology, VIC, Australia

1 To whom the correspondence should be addressed at: Centre for Women’s Health Research, Monash Institute of Medical Research, Monash University Department of Obstetrics and Gynaecology, 246 Clayton Road, VIC 3168, Australia. E-mail: peter.rogers{at}med.monash.edu.au

Annexin IV (ANXA4) belongs to a ubiquitous family of Ca2+-dependent phospholipid-binding proteins. ANXA4 has been shown to be involved in a range of physiological functions including ion channel regulation, exocytosis and Ca2+-dependent signal transduction. The aims of this study were to fully characterize ANXA4 mRNA and protein in human endometrium during the menstrual cycle and to investigate the hormonal regulation of ANXA4. ANXA4 mRNA expression was quantified by real-time PCR in fresh endometrial tissue from cycling women, and protein expression was analysed by immunohistochemistry and western blotting. Hormonal regulation of ANXA4 transcription and translation was investigated using an endometrial explant system. ANXA4 mRNA was significantly up-regulated during mid-secretory (MS) and late-secretory (LS) phases compared with proliferative phases during the menstrual cycle. ANXA4 protein was localized to glandular and luminal epithelium and was present in high levels throughout the menstrual cycle except during early-secretory (ES) phase, when it was significantly reduced. Our data also show that, in proliferative explants, progesterone significantly increased the ANXA4 mRNA and protein after 48h in culture. Estrogen did not have any significant effects. This is the first study to show that ANXA4 transcription and translation are regulated by progesterone and suggests that ANXA4 may be important in regulating ion and water transport across the endometrial epithelium.

Key words: ANXA4/endometrium/hormonal regulation/menstrual cycle


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
A. P Ponnampalam and P. A W Rogers
Expression and regulation of fucosyltransferase 4 in human endometrium
Reproduction, July 1, 2008; 136(1): 117 - 123.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.